Your browser doesn't support javascript.
loading
Research progress of SARS-CoV-2 main protease inhibitors / 药学学报
Acta Pharmaceutica Sinica ; (12): 2581-2600, 2023.
Artículo en Chino | WPRIM | ID: wpr-999009
ABSTRACT
As a common protease with high similarity among coronavirus species, the main protease (Mpro) of SARS-CoV-2 is responsible for the catalytic hydrolysis of viral precursor proteins into functional proteins, which is essential for coronavirus replication and is one of the ideal targets for the development of broad-spectrum antiviral drugs. This paper reviews the main protease inhibitors of SARS-CoV-2, including their molecular structures, potencies and drug-like profiles, binding modes and structure-activity relationships, etc.

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Idioma: Chino Revista: Acta Pharmaceutica Sinica Año: 2023 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Idioma: Chino Revista: Acta Pharmaceutica Sinica Año: 2023 Tipo del documento: Artículo